Evidence map›Paper›PMID 26712409›Full record

Trial reportJournal of clinical pharmacology2016

Mechanistic Population Pharmacokinetics of Morphine in Neonates With Abstinence Syndrome After Oral Administration of Diluted Tincture of Opium.

Tao Liu, Tamorah Lewis, Estelle Gauda, Jogarao Gobburu, Vijay Ivaturi

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of clinical pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Sedatives for opioid withdrawal in newborn infants.The Cochrane database of systematic reviews · 2021
    Pooled it
  2. Therapeutic approaches for neonatal abstinence syndrome: a systematic review of randomized clinical trials.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2019
    Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Integrated Review of the Assessment of Newborns With Neonatal Abstinence Syndrome.Journal of obstetric, gynecologic, and neonatal nursing : JOGNN · 2021
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Opioids: A Review of Pharmacokinetics and Pharmacodynamics in Neonates, Infants, and Children.European journal of drug metabolism and pharmacokinetics · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Tao LiuCenter for Translational Medicine, School of Pharmacy, University of Maryland, Baltimore, MD, USA.
Tamorah LewisDepartment of Pediatrics, Division of Neonatology, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Estelle GaudaDepartment of Pediatrics, Division of Neonatology, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Jogarao GobburuCenter for Translational Medicine, School of Pharmacy, University of Maryland, Baltimore, MD, USA.
Vijay IvaturiCenter for Translational Medicine, School of Pharmacy, University of Maryland, Baltimore, MD, USA.
University of Maryland, Baltimore · USJohns Hopkins Bayview Medical Center · USJohns Hopkins University · US

Funding

Clinical Pharmacology Training ProgramT32GM066691 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI Matthew Michael Ippolito · 2003 to 2026
$6.4M
Clonidine Treatment for Neonatal Abstinence SyndromeR21DA016288 · NIDA · JOHNS HOPKINS UNIVERSITY · PI GAUDA, ESTELLE B. · 2003 to 2006
$422k
NIDA NIH HHS R21 DA016288NIGMS NIH HHS T32 GM066691
6 · The paper itself

Abstract

Conducting and analyzing clinical trials in vulnerable neonates are extremely challenging. The aim of this analysis is to develop a morphine population pharmacokinetics (PK) model using data collected during a randomized control trial in neonates with abstinence syndrome (NAS). A 3-compartment morphine structural PK model after intravenous (IV) administration from previously published work was utilized as prior, whereas an allometric scaling method with physiological consideration was used to extrapolate a PK profile from adults to pediatrics. The absorption rate constant and bioavailability were estimated in NAS after oral administration of diluted tincture of opium (DTO). Goodness-of-fit plots along with normalized prediction distribution error and bootstrap method were performed for model evaluation. We successfully extrapolated the PK profile from adults to pediatrics after IV administration. The estimated first-order absorption rate constant and bioavailability were 0.751 hour(-1) and 48.5%, respectively. Model evaluations showed that the model can accurately and precisely describe the observed data. The population pharmacokinetic model we derived for morphine after oral administration of DTO is reasonable and acceptable; therefore, it can be used to describe the PK and guide future studies. The integration of the previous population PK knowledge as prior information successfully overcomes the logistic and practical issue in vulnerable neonate population.

Indexed as

Administration, OralAdultAnalgesics, OpioidDrug CompoundingFemaleHumansInfant, NewbornMaleMorphineNeonatal Abstinence SyndromeOpiumAnalgesics, OpioidMorphineOpiumbioavailabilitydiluted tincture of opiummorphineneonatal abstinence syndromeneonatepopulation pharmacokinetic model

Identifiers

PMID26712409
PMCPMC4927406
OpenAlexW2213706664

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.